Table 2.

Occurrence of grade III or higher adverse events during chemotherapy treatment.

	BBC+T (N = 30)	TBI+T (N = 18)
Adverse events (grade)	N (%)	N (%)
Anemia (III)	2 (6.7%)	0 (0%)
Cardiovascular system (III)	1 (3.3%)	1 (5.6%)
Edema (III)	1 (3.3%)	0 (0%)
GI perforation (III)	1 (3.3%)	0 (0%)
Hypertension (III)	4 (13.3%)	7 (38.9%)
Hypophosphatemia (III)	0 (0%)	1 (5.6%)
Leukopenia (III),	3 (10%)	4 (22.2%)
Leukopenia (IV)	3 (10%)	0 (0%)
Liver enzyme elevation (III)	1 (3.3%)	3 (16.7%)
Pneumonia (III)	1 (3.3%)	1 (5.6%)
Proteinuria (III)	1 (3.3%)	4 (22.2%)
Thrombocytopenia (III)	5 (16.7%)	1 (5.6%)
Thrombocytopenia (IV)	3 (10%)	1 (5.6%)
Venous thromboembolism* (III)	2 (6.7%)	2 (11.1%)
Weight Loss (III)	7 (23.3%)	2 (11.1%)

^*VTE, pulmonary embolism and deep venous thrombosis combined.